Mayla Hsu
Global Lyme Alliance(US)
Publications by Year
Research Areas
HIV Research and Treatment, HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, Hepatitis C virus research, Hepatitis B Virus Studies
Most-Cited Works
- → Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles(2003)774 cited
- → Entecavir resistance is rare in nucleoside naïve patients with hepatitis B(2006)347 cited
- → Enhanced Fidelity of 3TC-Selected Mutant HIV-1 Reverse Transcriptase(1996)303 cited
- → Two-Year Assessment of Entecavir Resistance in Lamivudine-Refractory Hepatitis B Virus Patients Reveals Different Clinical Outcomes Depending on the Resistance Substitutions Present(2006)239 cited
- → Increased Mucosal Transmission but Not Enhanced Pathogenicity of the CCR5-Tropic, Simian AIDS-Inducing Simian/Human Immunodeficiency Virus SHIV SF162P3 Maps to Envelope gp120(2002)84 cited
- → An Antiretroviral/Zinc Combination Gel Provides 24 Hours of Complete Protection against Vaginal SHIV Infection in Macaques(2011)83 cited
- → A Novel Small Molecule Inhibitor of Hepatitis C Virus Entry(2010)82 cited
- → Higher fidelity of RNA-dependent DNA mispair extension by M184V drug- resistant than wild-type reverse transcriptase of human immunodeficiency virus type 1(1997)68 cited
- → Estimation of cumulative number of post-treatment Lyme disease cases in the US, 2016 and 2020(2019)58 cited
- → Roles of the Human Immunodeficiency Virus Type 1 Nucleocapsid Protein in Annealing and Initiation versus Elongation in Reverse Transcription of Viral Negative-Strand Strong-Stop DNA(1998)52 cited